Linperlisib in the Treatment of aPRCA

Clinical trial NCT07031115 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07031115
Sponsor: Peking Union Medical College Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acquired Pure Red Cell Aplasia

Start date: 2025-09-01
Primary completion: 2025-12-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.